Does RIBOCICLIB Cause Nasopharyngitis? 510 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 510 reports of Nasopharyngitis have been filed in association with RIBOCICLIB (KISQALI). This represents 1.8% of all adverse event reports for RIBOCICLIB.
510
Reports of Nasopharyngitis with RIBOCICLIB
1.8%
of all RIBOCICLIB reports
30
Deaths
160
Hospitalizations
How Dangerous Is Nasopharyngitis From RIBOCICLIB?
Of the 510 reports, 30 (5.9%) resulted in death, 160 (31.4%) required hospitalization, and 54 (10.6%) were considered life-threatening.
Is Nasopharyngitis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RIBOCICLIB. However, 510 reports have been filed with the FAERS database.
What Other Side Effects Does RIBOCICLIB Cause?
Neutropenia (3,585)
Nausea (3,404)
Fatigue (3,327)
Malignant neoplasm progression (2,468)
Death (2,452)
Vomiting (1,953)
Diarrhoea (1,830)
White blood cell count decreased (1,683)
Pain (1,637)
Metastases to bone (1,538)
What Other Drugs Cause Nasopharyngitis?
ADALIMUMAB (13,753)
ETANERCEPT (12,421)
METHOTREXATE (8,046)
TOFACITINIB (7,781)
SECUKINUMAB (7,022)
TOCILIZUMAB (6,664)
RITUXIMAB (6,321)
ABATACEPT (6,143)
INFLIXIMAB (5,353)
CERTOLIZUMAB PEGOL (5,295)
Which RIBOCICLIB Alternatives Have Lower Nasopharyngitis Risk?
RIBOCICLIB vs RIBOFLAVIN
RIBOCICLIB vs RIBOFLAVIN 5'-PHOSPHATE
RIBOCICLIB vs RIBOFLAVIN 5^-PHOSPHATE
RIBOCICLIB vs RIFABUTIN
RIBOCICLIB vs RIFAMPICIN